ArticleBlood advances2019

Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasone.

Efstathios Kastritis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.